Supplemental material
Open access
1,290
Views
0
CrossRef citations to date
0
Altmetric
Novel Vaccines
Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides
Kirsty Le Doarea Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, St George’s, University of London, London, UK;b Makerere University Johns Hopkins University, Kampala, Uganda;c UK Health Security Agency, Porton Down, UKView further author information
, Michelle A. Gaylordd Pfizer Vaccine Research & Development, Pearl River, NY, USAView further author information
, Annaliesa S. Andersond Pfizer Vaccine Research & Development, Pearl River, NY, USAView further author information
, Nick Andrewse Immunisation and Vaccine Preventable Diseases Division, United Kingdom Health Security Agency (UKHSA), London, UKView further author information
, Carol J. Bakerf Department of Pediatrics, Division of Infectious Disease, McGovern Medical School and UT Health, Houston, TX, USAView further author information
, Shanna Bolceng The Centers for Disease Control and Prevention (CDC), Atlanta, GA, USAView further author information
, Arif Felekh Vaccine Division, Scientific Research & Innovation Group, MHRA, Potters Bar, UKView further author information
, Peter C. Giardinad Pfizer Vaccine Research & Development, Pearl River, NY, USAView further author information
, Christopher D. Grubed Pfizer Vaccine Research & Development, Pearl River, NY, USAView further author information
, Tom Halla Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, St George’s, University of London, London, UKCorrespondence[email protected]
https://orcid.org/0000-0002-9001-6684View further author information
Bassam Hallisc UK Health Security Agency, Porton Down, UKView further author information
, Alane Izui South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;j Department of Science/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South AfricaView further author information
, Shabir A. Madhii South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;j Department of Science/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South AfricaView further author information
, Pete Maniatisg The Centers for Disease Control and Prevention (CDC), Atlanta, GA, USAView further author information
, Mary Mathesonc UK Health Security Agency, Porton Down, UKView further author information
, Fatme Mawash Vaccine Division, Scientific Research & Innovation Group, MHRA, Potters Bar, UKView further author information
, Andrew McKeenk Pfizer Global Biometrics & Data Management, Pearl River, NY, USAView further author information
, Julia Rhodesg The Centers for Disease Control and Prevention (CDC), Atlanta, GA, USAView further author information
, Bailey Alstonl Eagle Global Scientific, Atlanta, GA, USAView further author information
, Palak Patelg The Centers for Disease Control and Prevention (CDC), Atlanta, GA, USAView further author information
, Stephanie Schragg The Centers for Disease Control and Prevention (CDC), Atlanta, GA, USAView further author information
, Raphael Simond Pfizer Vaccine Research & Development, Pearl River, NY, USAView further author information
, Charles Y. Tank Pfizer Global Biometrics & Data Management, Pearl River, NY, USAView further author information
, Stephen Taylorc UK Health Security Agency, Porton Down, UKView further author information
, Gaurav Kwatrai South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;j Department of Science/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa;m Department of Clinical Microbiology, Christian Medical College, Vellore, IndiaView further author information
& Andrew Gorringec UK Health Security Agency, Porton Down, UKView further author information
show all
Article: 2330138
|
Received 30 Nov 2023, Accepted 09 Mar 2024, Published online: 12 Apr 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.